Pages that link to "Q35605499"

The following pages link to Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study (Q35605499):

Displaying 40 items.

• The opioid epidemic and neonatal abstinence syndrome in the USA: a review of the continuum of care (Q30239085) (← links)
• Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects. (Q30249670) (← links)
• Identification of smoking using Medicare data--a validation study of claims-based algorithms (Q31036793) (← links)
• Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National Guidance (Q33760424) (← links)
• Opioid use during pregnancy: a population-based cohort study (Q33875076) (← links)
• Birth and Neonatal Outcomes Following Opioid Use in Pregnancy: A Danish Population-Based Study (Q36142245) (← links)
• Zidovudine use in pregnancy and congenital malformations (Q36379162) (← links)
• Consequences of prenatal opioid use for newborns (Q38547160) (← links)
• Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study (Q38646134) (← links)
• Antipsychotic Medication Use Among Publicly Insured Pregnant Women in the United States (Q38724641) (← links)
• Comparison of Time to First Dose of Oral Morphine in the Treatment of Neonatal Abstinence Syndrome (Q38788360) (← links)
• Ongoing Pharmacological Management of Chronic Pain in Pregnancy (Q38827847) (← links)
• Nonmedical Use of Prescription Opioids among Pregnant U.S. Women (Q38837808) (← links)
• Transmission of risk from parents with chronic pain to offspring: an integrative conceptual model (Q38845051) (← links)
• Neonatal Abstinence Syndrome: Trend and Expenditure in Louisiana Medicaid, 2003-2013. (Q38974923) (← links)
• Opioid Use Disorder in Pregnancy. (Q39340617) (← links)
• Epidemiological Evidence for a Decreasing Incidence of Neonatal Abstinence Syndrome, 2000-11. (Q40020329) (← links)
• Trends of Neonatal Abstinence Syndrome Epidemic and Maternal Risk Factors in Florida (Q40202958) (← links)
• Angiotensin-Converting Enzyme Inhibitors and the Risk of Congenital Malformations (Q40437479) (← links)
• Late Pregnancy β Blocker Exposure and Risks of Neonatal Hypoglycemia and Bradycardia (Q40601235) (← links)
• Simplification of the Finnegan Neonatal Abstinence Scoring System: retrospective study of two institutions in the USA. (Q42172730) (← links)
• Decreasing Total Medication Exposure and Length of Stay While Completing Withdrawal for Neonatal Abstinence Syndrome during the Neonatal Hospital Stay (Q42700561) (← links)
• Methadone versus buprenorphine for opioid use dependence and risk of neonatal abstinence syndrome (Q44350531) (← links)
• Review of Post-Marketing Safety Data on Tapentadol, a Centrally Acting Analgesic (Q47261672) (← links)
• Placental Complications Associated With Psychostimulant Use in Pregnancy (Q47616895) (← links)
• Maternal buprenorphine treatment and infant outcome (Q47712360) (← links)
• The Role of Preterm Birth in the Association Between Opioid Maintenance Therapy and Neonatal Abstinence Syndrome (Q48160111) (← links)
• Neonatal abstinence syndrome: an update (Q49966520) (← links)
• Mental Health of Mothers of Infants with Neonatal Abstinence Syndrome and Prenatal Opioid Exposure (Q50126036) (← links)
• Analysis of the factors that influence the Finnegan Neonatal Abstinence Scoring System (Q50746005) (← links)
• Commentary on Gibson et al. (2017): Gestational age and the severity of neonatal abstinence syndrome. (Q52312251) (← links)
• The Epidemic of Neonatal Abstinence Syndrome, Historical References of Its' Origins, Assessment, and Management. (Q52665558) (← links)
• Neonatal Abstinence Syndrome (NAS) in Southwestern Border States: Examining Trends, Population Correlates, and Implications for Policy. (Q54249568) (← links)
• Early life stress and environmental influences on the neurodevelopment of children with prenatal opioid exposure (Q57169315) (← links)
• CYP450 genotype and pharmacogenetic association studies: a critical appraisal (Q57585515) (← links)
• Update of the Scientific Opinion on opium alkaloids in poppy seeds (Q62086883) (← links)
• Research and policy priorities for addressing prenatal exposure to opioids in Alaska (Q64088919) (← links)
• Positive Predictive Value of Administrative Data for Neonatal Abstinence Syndrome (Q64135194) (← links)
• Opioid Use in Pregnant Women and Neonatal Abstinence Syndrome-A Review of the Literature (Q64230197) (← links)
• Substance use in pregnancy: The medical challenge (Q89576761) (← links)